Veradigm | MDRX - Loan Capital


Veradigm reported $200.4M in Loan Capital for its fiscal quarter ending in December of 2022.





Loan Capital Change Date
Alcidion AUD 318K 376K Dec/2025
Ambu A/S DKK 14M 448M Dec/2025
Amplifon EUR 1.11B 304.77M Sep/2025
Cardinal Health USD 8.35B 633M Dec/2025
Centene USD 17.35B 194M Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Cigna USD 30.95B 4.47B Sep/2025
Coloplast 21.39B 1.34B Dec/2025
Computer Programs Systems USD 161.24M 122K Dec/2025
Convatec Group USD 1.18B 211.4M Dec/2024
CVS Health USD 60.5B 6M Dec/2025
Diasorin EUR 472.05M 199.95M Jun/2025
Elevance Health USD 30.8B 376M Dec/2025
General Electric Aerospace USD 18.81B 37M Dec/2025
Gulf Medical Proj AED 3.1M 151K Dec/2025
Humana USD 12.37B 238M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Maximus USD 1.51B 227.61M Dec/2025
McKesson USD 5.43B 586M Dec/2025
Med Life RON 1.71B 260.03M Dec/2025
Molina Healthcare USD 3.95B 98M Dec/2025
Omnicell USD 167.6M 302K Dec/2025
Oriola-kd EUR 38.3M 600K Dec/2025
Owens Minor USD 1.8B 35.38M Dec/2025
Quest Diagnostics USD 5.17B 4M Dec/2025
Rede D'or Sao Luiz BRL 47.49B 2.56B Dec/2025
Siemens Healthineers EUR 9.85B 1.49B Dec/2025
Sonova Holding CHF 1.39B 209.8M Jun/2025
Supermax Corporation Bhd MYR 17.03M 581K Dec/2025
UnitedHealth USD 72.32B 79M Dec/2025
Veradigm USD 200.4M 69K Dec/2022
Xerox USD 3.48B 785M Jun/2025